Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Judith H. LaPierre
Observed names:
Judith Lapierre,
LaPierre, Judith
Institution:
Lady Davis Institute for Medical Research
Observed institutions:
Jewish General Hospital,
Lady Davis Institute for Medical Research,
University of Manitoba,
McGill University
ORCID:
0000-0002-2243-6580
Observed ORCID:
0000-0002-2243-6580
OpenAlex ID:
A5019520769
Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma
2023
·
Fan Huang
, Feiyang Cai
, et al.
·
Journal of Clinical Investigation
·
54
PDF
Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2022
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
·
Molecular Cancer Therapeutics
·
11
PDF
Molecular pathways of immune checkpoint inhibitor–induced hepatitis.
2026
·
Erika Bushatsky
, Natasha Ryan
, et al.
·
Journal of Clinical Oncology
Supplementary Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 2 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Figure 1 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Figure 3 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Methods and Tables from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 1 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 3 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Methods and Tables from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 2 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 2 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Figure 3 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Show more works
View as search
Works count:
19
Citation count:
65
H-index:
2
I10-index:
2
Year
Topic
Type